News

Press Release

May 11, 2026

CPTx appoints Edward Rebar as Chief Scientific Officer

Read More
May 4, 2026

CPTx to present preclinical proof-of-principle of its DNA-based in vivo CAR T platform at ASGCT Annual Meeting

Read More
January 23, 2026

Hendrik Dietz on “Making CAR T Truly Off the Shelf”

Read More Hendrik Dietz headshot
October 7, 2025

CPTx Unveils New Data at ESGCT Supporting ssDNA + LNP “Third Path” for In Vivo CAR-T

Read More ssDNA image
September 2, 2025

What role is precision medicine playing in transforming cancer treatment — and how are developers adapting?

Read More
August 14, 2025

CPTx & NanoCell Therapeutics Project Awarded EU Funding for Innovative In Vivo CAR T Therapy with Immune-Silent Single-Stranded DNA

Read More
July 1, 2025

Opening new doors to precision medicine with single-stranded DNA (ssDNA): part 2

Read More
July 1, 2025

Opening new doors to precision medicine with single-stranded DNA (ssDNA): part I

Read More
June 16, 2025

What role is precision medicine playing in transforming cancer treatment — and how are developers adapting?

Read More